Advertisement

Normal Glucose Homeostasis

  • Mazen Alsahli
  • Muhammad Z. Shrayyef
  • John E. GerichEmail author
Reference work entry

Abstract

This chapter discusses normal glucose physiology. It reviews the regulation of glucose production and utilization by complex mechanisms that are influenced by the nervous system, several hormones, and substrates all tightly linked so as to maintain optimal glucose homeostasis.

Keywords

Glucagon Gluconeogenesis Glucose homeostasis Glucose metabolism Glucose physiology Glycogenolysis Insulin Normal glucose Postabsorptive state Postprandial state 

References

  1. 1.
    Rizza R, Gerich J, Haymond M, Westland R, Hall L, Clemens A, Service F. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, subcutaneous insulin infusion and intensified conventional insulin therapy. N Engl J Med. 1980;303:1313–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Wahren J, Felig P, Hagenfeldt L. Physical exercise and fuel homeostasis in diabetes mellitus. Diabetologia. 1978;14:213–22.PubMedCrossRefGoogle Scholar
  3. 3.
    Consoli A, Kennedy F, Miles J, Gerich J. Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man. J Clin Invest. 1987;80:1303–10.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Gerich J. Control of glycaemia. Bailliere Clin Endocrinol Metab. 1993;7:551–86.CrossRefGoogle Scholar
  5. 5.
    Gerich J. Glucose counterregulation and its impact on diabetes mellitus. Diabetes. 1988;37:1608–17.PubMedCrossRefGoogle Scholar
  6. 6.
    Siesjo BK. Hypoglycemia, brain metabolism, and brain damage. Diabetes Metab Rev. 1988;4:113–44.PubMedCrossRefGoogle Scholar
  7. 7.
    Owen O, Morgan A, Kemp H, Sullivan J, Herrera M, Cahill G. Brain metabolism during fasting. J Clin Invest. 1967;46:1589–95.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67–74.PubMedGoogle Scholar
  9. 9.
    Jarrett RJ, Keen H. Hyperglycaemia and diabetes mellitus. Lancet. 1976;2:1009–12.PubMedCrossRefGoogle Scholar
  10. 10.
    Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Diabetes Care. 1999;22:920–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia. 1978;15:143–52.PubMedCrossRefGoogle Scholar
  12. 12.
    Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Archangeli M, Aoki T, Sorensen J, Berger M, Sonksen P, Gerich J. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest. 1988;81:1563–71.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Bouche C, Serdy S, Kahn CR, Goldfine AB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev. 2004;25:807–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Gottesman I, Mandarino L, Gerich J. Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo. Diabetes. 1984;33:184–91.PubMedCrossRefGoogle Scholar
  15. 15.
    Rodnick KJ, Piper RC, Slot JW, James DE. Interaction of insulin and exercise on glucose transport in muscle. Diabetes Care. 1992;15:1679–89.PubMedCrossRefGoogle Scholar
  16. 16.
    Wright EM. Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol. 2001;280:F10–8.PubMedGoogle Scholar
  17. 17.
    Bonner C, Kerr-Conte J, Gmyr V, Queniat G, Moerman E, Thévenet J, Beaucamps C, Delalleau N, Popescu I, Malaisse WJ, Sener A, Deprez B, Abderrahmani A, Staels B, Pattou F. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med. 2015;21(5):512–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Scafoglio C, Hirayama BA, Kepe V, Liu J, Ghezzi C, Satyamurthy N, Moatamed NA, Huang J, Koepsell H, Barrio JR, Wright EM. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015;112(30):E4111–9. doi:10.1073/pnas.1511698112.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Mueckler M. Family of glucose-transporter genes implications for glucose homeostasis and diabetes. Diabetes. 1990;39:6–11.PubMedCrossRefGoogle Scholar
  20. 20.
    Cushman S, Wardzala L. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biochem. 1980;255:4728–62.Google Scholar
  21. 21.
    Mogensen CE. Maximum tubular reabsorption capacity for glucose and renal hemodynamics during rapid hypertonic glucose infusion in normal and diabetic subjects. Scand J Clin Lab Invest. 1971;28:101–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Dominguez JH, Camp K, Maianu L, Feister H, Garvey WT. Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. Am J Physiol. 1994;266(2, Pt 2):F283–90.PubMedGoogle Scholar
  23. 23.
    Rorsman P, Ramracheya R, Rorsman NJ, Zhang Q. ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion. Diabetologia. 2014;57(9):1749–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Komala MG, Panchapakesan U, Pollock C, Mather A. Sodium glucose cotransporter 2 and the diabetic kidney. Curr Opin Nephrol Hypertens. 2013;22(1):113–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Ghezzi C, Wright EM. Regulation of the human Na+-dependent glucose cotransporter hSGLT2. Am J Physiol Cell Physiol. 2012;303(3):C348–54.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Osorio H, Bautista R, Rios A, et al. Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats. Diabetes Res Clin Pract. 2009;86:e46–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Meyer C, Dostou J, Nadkarni V, Gerich J. Effects of physiological hyperinsulinemia on systemic, renal and hepatic substrate metabolism. Am J Physiol. 1998;275:F915–21.PubMedGoogle Scholar
  28. 28.
    Oster-Jorgensen E, Pedersen SA, Larsen ML. The influence of induced hyperglycaemia on gastric emptying rate in healthy humans. Scand J Clin Lab Invest. 1990;50:831–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Meyer C, Nadkarni V, Stumvoll M, Gerich J. Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle. Am J Physiol. 1997;273:E650–4.PubMedGoogle Scholar
  30. 30.
    Gerich JE. Physiology of glucose homeostasis. Diabetes Obes Metab. 2000;2:345–50.PubMedCrossRefGoogle Scholar
  31. 31.
    Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Haring H, Fritsche A, Gerich J. Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes. Diabetes Care. 2000;23:1440–1.PubMedCrossRefGoogle Scholar
  32. 32.
    Woerle HJ, Meyer C, Dostou JM, Gosmanov NR, Islam N, Popa E, Wittlin SD, Welle SL, Gerich JE. Pathways for glucose disposal after meal ingestion in humans. Am J Physiol Endocrinol Metab. 2003;284:E716–25.PubMedCrossRefGoogle Scholar
  33. 33.
    Bolli G, Gottesman I, Cryer P, Gerich J. Glucose counterregulation during prolonged hypoglycemia in normal humans. Am J Physiol. 1984;247:E206–14.PubMedGoogle Scholar
  34. 34.
    Jones PM, Shanta J, Persaud SJ. Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic β-cells. Endocr Rev. 1998;19(4):429–61.PubMedGoogle Scholar
  35. 35.
    Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care. 2005;28:1124–31.PubMedCrossRefGoogle Scholar
  36. 36.
    Magnusson I, Rothman D, Gerard D, Katz L, Shulman G. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes. 1995;44:185–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Gerich J. Physiology of glucagon. Int Rev Physiol. 1981;24:244–75.Google Scholar
  38. 38.
    Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev. 2007;28:84–116.PubMedCrossRefGoogle Scholar
  39. 39.
    Lecavalier L, Bolli G, Cryer P, Gerich J. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol. 1989;256:E844–51.PubMedGoogle Scholar
  40. 40.
    Heimberg H, de Vos A, Pipeleers D, Thorens B, Schuit F. Differences in glucose transporter gene expression between rat pancreatic alpha- and beta-cells are correlated to differences in glucose transport but not in glucose utilization. J Biol Chem. 1995;270:8971–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Ferrannini E, Muscelli E, Frascerra S, Baldi S, Mari A, Heise T, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest. 2014;124:499–508.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Merovci A, Solis-Herrera C, Daniele G, Eldor R, Fiorentino TV, Tripathy D, et al. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. J Clin Invest. 2014;124:509–14.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Munoz A, Hu M, Hussain K, Bryan J, Aguilar-Bryan L, Rajan AS. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement. Endocrinology. 2005;146:5514–21.PubMedCrossRefGoogle Scholar
  44. 44.
    Gerich J, Cryer P, Rizza R. Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone and cortisol. Metabolism. 1980;29 Suppl 1:1164–75.PubMedCrossRefGoogle Scholar
  45. 45.
    Rizza R, Cryer P, Haymond M, Gerich J. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man. Metabolism. 1980;29(Suppl):1155–63.PubMedCrossRefGoogle Scholar
  46. 46.
    Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J. Uptake and release of glucose by the human kidney: postabsorptive rates and responses to epinephrine. J Clin Invest. 1995;96:2528–33.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    DeFeo P, Perriello G, Torlone E, Fanelli C, Ventura M, Santeussanio F, Brunetti P, Gerich J, Bolli G. Contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol. 1991;261:E725–36.Google Scholar
  48. 48.
    Rizza R, Mandarino L, Gerich J. Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilization. Diabetes. 1982;31:663–9.PubMedCrossRefGoogle Scholar
  49. 49.
    DeFeo P, Perriello G, Torlone E, Ventura M, Santeusanio F, Brunetti P, Gerich J, Bolli G. Demonstration of a role of growth hormone in glucose counterregulation. Am J Physiol. 1989;256:E835–43.Google Scholar
  50. 50.
    DeFeo P, Perriello G, Torlone E, Ventura M, Fanelli C, Santeusanio F, Brunetti P, Gerich J, Bolli G. Contribution of cortisol to glucose counterregulation in humans. Am J Physiol. 1989;257:E35–42.Google Scholar
  51. 51.
    Fanelli C, Calderone S, Epifano L, DeVincenzo A, Modarelli F, Perriello G, DeFeo P, Brunetti P, Gerich J, Bolli G. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest. 1993;92:1617–22.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Cahill G. Starvation in man. N Engl J Med. 1970;282:668–75.PubMedCrossRefGoogle Scholar
  53. 53.
    Havel R. Caloric homeostasis and disorders of fuel transport. N Engl J Med. 1972;287:1186–92.PubMedCrossRefGoogle Scholar
  54. 54.
    Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46:3–10.PubMedCrossRefGoogle Scholar
  55. 55.
    McGarry J. Glucose-fatty acid interactions in health and disease. Am J Clin Nutr. 1998;67(3 Suppl):500S–4.PubMedGoogle Scholar
  56. 56.
    Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–57.PubMedCrossRefGoogle Scholar
  57. 57.
    Brown JC, Dryburgh JR, Ross SA, Dupre J. Identification and actions of gastric inhibitory polypeptide. Recent Prog Horm Res. 1975;31:487–532.PubMedGoogle Scholar
  58. 58.
    Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hufner M, Schmiegel WH. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab. 2002;87:1239–46.PubMedCrossRefGoogle Scholar
  59. 59.
    Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371–81.PubMedCrossRefGoogle Scholar
  60. 60.
    Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia. 1993;36:857–62.PubMedCrossRefGoogle Scholar
  61. 61.
    Jones KL, Horowitz M, Carney BI, Wishart JM, Guha S, Green L. Gastric emptying in early noninsulin-dependent diabetes mellitus. J Nucl Med. 1996;37:1643–8.PubMedGoogle Scholar
  62. 62.
    MacGregor IL, Gueller R, Watts HD, Meyer JH. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology. 1976;70:190–6.PubMedGoogle Scholar
  63. 63.
    Bjornsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H. Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol. 1994;29:1096–104.PubMedCrossRefGoogle Scholar
  64. 64.
    Karamanlis A, Chaikomin R, Doran S, Bellon M, Bartholomeusz FD, Wishart JM, Jones KL, Horowitz M, Rayner CK. Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am J Clin Nutr. 2007;86:1364–8.PubMedGoogle Scholar
  65. 65.
    Gentilcore D, Chaikomin R, Jones KL, Russo A, Feinle-Bisset C, Wishart JM, Rayner CK, Horowitz M. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metab. 2006;91:2062–7.PubMedCrossRefGoogle Scholar
  66. 66.
    Gerich JE, Meyer C, Woerle HJ, Stumvoll M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care. 2001;2:382–91.CrossRefGoogle Scholar
  67. 67.
    Bjorkman O, Felig P, Wahren J. The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans. Diabetes. 1980;8:610–6.CrossRefGoogle Scholar
  68. 68.
    Ekberg K, Landau BR, Wajngot A, Chandramouli V, Efendic S, Brunengraber H, et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 1999;2:292–8.CrossRefGoogle Scholar
  69. 69.
    Meyer C, Dostou JM, Gerich JE. Role of the human kidney in glucose counterregulation. Diabetes. 1999;5:943–8.CrossRefGoogle Scholar
  70. 70.
    Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes. 1999;2:261–6.CrossRefGoogle Scholar
  71. 71.
    Meyer C, Dostou JM, Welle SL, Gerich JE. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab. 2002;2:E419–27.CrossRefGoogle Scholar
  72. 72.
    Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med. 2010;2:136–42.CrossRefGoogle Scholar
  73. 73.
    Wright EM, Hirayama BA, Loo DF. Active sugar transport in health and disease. J Intern Med. 2007;1:32–43.CrossRefGoogle Scholar
  74. 74.
    Wright EM. Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol. 2001;1:F10–8.Google Scholar
  75. 75.
    Brown GK. Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis. 2000;3:237–46.CrossRefGoogle Scholar
  76. 76.
    Hediger MA, Rhoads DB. Molecular physiology of sodium-glucose cotransporters. Physiol Rev. 1994;4:993–1026.Google Scholar
  77. 77.
    Zelikovic I. Aminoaciduria and glycosuria. In: Avner ED, Harmon WE, Niaudet P, editors. Pediatric nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 701–28.Google Scholar
  78. 78.
    Moe O, Wright S, Palacin M. Renal handling of organic solutes. In: Brenner BM, editor. Brenner & Rector’s the kidney. 8th ed. Philadelphia: Saunders Elsevier; 2008. p. 214–47.Google Scholar
  79. 79.
    Gerich J. Hepatorenal glucose reciprocity in physiologic and pathologic conditions. Diabetes Nutr Metab. 2002;15:298–302.PubMedGoogle Scholar
  80. 80.
    Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest. 1998;102:619–24.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Stumvoll M, Meyer C, Kreider M, Perriello G, Gerich J. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism. 1998;47:1227–32.PubMedCrossRefGoogle Scholar
  82. 82.
    Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol. 1998;274:E817–26.PubMedGoogle Scholar
  83. 83.
    Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes. 1999;48:261–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Cersosimo E, Garlick P, Ferretti J. Insulin regulation of renal glucose metabolism in humans. Am J Physiol. 1999;276:E78–84.PubMedGoogle Scholar
  85. 85.
    Ekberg K, Landau B, Wajngot A, Chandramouli V, Efendic S, Brunengraber H, Wahren J. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 1999;48:292–8.PubMedCrossRefGoogle Scholar
  86. 86.
    Cersosimo E, Garlick P, Ferretti J. Regulation of splanchnic and renal substrate supply by insulin in humans. Metabolism. 2000;49:676–83.PubMedCrossRefGoogle Scholar
  87. 87.
    Cersosimo E, Garlick P, Ferretti J. Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes. 2000;49:1186–93.PubMedCrossRefGoogle Scholar
  88. 88.
    Moller N, Rizza R, Ford G, Nair K. Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers. Diabetes. 2001;50:747–51.PubMedCrossRefGoogle Scholar
  89. 89.
    Meyer C, Dostou J, Welle S, Gerich J. Role of human liver, kidney and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab. 2002;282:E419–27.PubMedCrossRefGoogle Scholar
  90. 90.
    Garcia-Ruiz J, Moreno F, Sanchez-Medina F, Mayor F. Stimulation of rat kidney phosphoenolpyruvate carboxykinase activity in experimental liver disease induced by galactosamine. FEBS Lett. 1973;34:13–6.CrossRefGoogle Scholar
  91. 91.
    Bergman H, Drury DR. The relationship of kidney function to the glucose utilization of the extra abdominal tissues. Am J Physiol. 1938;124:279–84.Google Scholar
  92. 92.
    Drury D, Wick A, MacKay E. Formation of glucose by the kidney. Am J Physiol. 1950;165:655–61.Google Scholar
  93. 93.
    Joseph S, Heaton N, Potter D, Pernet A, Umpleby M, Amiel S. Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes. 2000;49:450–6.PubMedCrossRefGoogle Scholar
  94. 94.
    Battezzati A, Fattorini A, Caumo A, Coppa J, Romito R, Regalia E, Matthews D, Mazzaferro V, Luzi L. Non-hepatic glucose production in humans. Diabetes. 1999;48 Suppl 1:A49.Google Scholar
  95. 95.
    Schoolwerth A, Smith B, Culpepper R. Renal gluconeogenesis. Miner Electrolyte Metab. 1988;14:347–61.PubMedGoogle Scholar
  96. 96.
    Iles R, Cohen R, Rist A, Baron P. The mechanism of inhibition by acidosis of gluconeogenesis from lactate in rat liver. Biochem J. 1977;164:185–91.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Aber G, Morris L, Housley E. Gluconeogenesis by the human kidney. Nature. 1966;212:1589–90.PubMedCrossRefGoogle Scholar
  98. 98.
    Gerich J. Hypoglycaemia and counterregulation in type 2 diabetes. Lancet. 2000;356:1946–7.PubMedCrossRefGoogle Scholar
  99. 99.
    Meyer C, Dostou J, Gerich J. Role of the human kidney in glucose counterregulation. Diabetes. 1999;48:943–8.PubMedCrossRefGoogle Scholar
  100. 100.
    Cersosimo E, Garlick P, Ferretti J. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes. Diabetes. 2001;50:2087–93.PubMedCrossRefGoogle Scholar
  101. 101.
    Woerle HJ, Meyer C, Popa E, Cryer P, Gerich J. Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes. Diabetologia. 2001;44 Suppl 1:A67.Google Scholar
  102. 102.
    Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich J. Renal glucose production and utilization: new aspects in humans. Diabetologia. 1997;40:749–57.PubMedCrossRefGoogle Scholar
  103. 103.
    Landau B, Wahren J, Chandramouli V, Schuman W, Ekberg K, Kalhan S. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest. 1996;98:378–85.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Nilsson L, Hultman E. Liver glycogen in man – the effect of total starvation or a carbohydrate-poor diet followed by refeeding. Scand J Clin Lab Invest. 1973;32:325–30.PubMedCrossRefGoogle Scholar
  105. 105.
    Perriello G, Jorde R, Nurjhan N, Stumvoll M, Dailey G, Jenssen T, Bier D, Gerich J. Estimation of the glucose-alanine-lactate-glutamine cycles in postabsorptive man: role of the skeletal muscle. Am J Physiol. 1995;269:E443–50.PubMedGoogle Scholar
  106. 106.
    McMahon M, Marsh H, Rizza R. Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal. J Clin Endocrinol Metab. 1989;68:647–53.PubMedCrossRefGoogle Scholar
  107. 107.
    Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in noninsulin-dependent diabetes mellitus. N Engl J Med. 1992;327:707–13.PubMedCrossRefGoogle Scholar
  108. 108.
    Marin P, Hogh-Kristiansen I, Jansson S, Krotkiewski M, Holm G, Bjorntorp P. Uptake of glucose carbon in muscle glycogen and adipose tissue triglycerides in vivo in humans. Am J Physiol. 1992;263:E473–80.PubMedGoogle Scholar
  109. 109.
    Meyer C, Dostou J, Welle S, Gerich J. Role of liver, kidney and skeletal muscle in the disposition of an oral glucose load. Diabetes. 1999;48 Suppl 1:A289.Google Scholar
  110. 110.
    Kelley D, Mokan M, Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism. 1994;43:1549–57.PubMedCrossRefGoogle Scholar
  111. 111.
    Butler P, Kryshak E, Rizza R. Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans. Am J Physiol. 1991;260:E513–20.PubMedGoogle Scholar
  112. 112.
    Ferrannini E, Bjorkman O, Reichard G, Pilo A, Olsson M, Wahren J, DeFronzo R. The disposal of an oral glucose load in healthy subjects: a quantitative study. Diabetes. 1985;34:580–8.PubMedCrossRefGoogle Scholar
  113. 113.
    Jackson R, Roshania R, Hawa M, Sim B, DiSilvio L. Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques. J Clin Endocrinol Metab. 1986;63:541–9.PubMedCrossRefGoogle Scholar
  114. 114.
    McMahon M, Marsh H, Rizza R. Effects of basal insulin supplementation on disposition of a mixed meal in obese patients with NIDDM. Diabetes. 1989;38:291–303.PubMedCrossRefGoogle Scholar
  115. 115.
    Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med. 1992;326:22–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Beckmann N, Fried R, Turkalj I, Seelig J, Keller U, Stalder G. Noninvasive observation of hepatic glycogen formation in man by 13C MRS after oral and intravenous glucose administration. Magn Reson Med. 1993;29:583–90.PubMedCrossRefGoogle Scholar
  117. 117.
    Petersen K, Cline G, Gerard D, Magnusson I, Rothman D, Shulman G. Contribution of net hepatic glycogen synthesis to disposal of an oral glucose load in humans. Metabolism. 2001;50:598–601.PubMedCrossRefGoogle Scholar
  118. 118.
    Taylor R, Magnusson I, Rothman D. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest. 1996;97:126–32.PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Mitrakou A, Jones R, Okuda Y, Pena J, Nurjhan N, Field J, Gerich J. Pathway and carbon sources for hepatic glycogen repletion in the dog. Am J Physiol. 1991;260:E194–202.PubMedGoogle Scholar
  120. 120.
    Firth R, Bell P, Marsh H, Hansen I, Rizza R. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest. 1986;77:1525–32.PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Taylor R, Price T, Katz L, Shulman R, Shulman G. Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects. Am J Physiol. 1993;265:E224–9.PubMedGoogle Scholar
  122. 122.
    Radziuk J, Inculet R. The effects of ingested and intravenous glucose on forearm uptake of glucose and glucogenic substrate in normal man. Diabetes. 1983;32:977–81.PubMedCrossRefGoogle Scholar
  123. 123.
    Ferrannini E, Wahren J, Felig P, DeFronzo R. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism. 1980;29:28–35.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Mazen Alsahli
    • 1
    • 4
  • Muhammad Z. Shrayyef
    • 2
  • John E. Gerich
    • 3
    Email author
  1. 1.Southlake Regional Health CenterNewmarketCanada
  2. 2.Faculty of MedicineUniversity of TorontoTorontoCanada
  3. 3.Department of MedicineUniversity of Rochester School of MedicineRochesterUSA
  4. 4.Department of MedicineUniversity of TorontoTorontoCanada

Personalised recommendations